APA (7th ed.) Citation

Antonioli, L., Pellegrini, C., Fornai, M., Benvenuti, L., D'Antongiovanni, V., Colucci, R., . . . Haskó, G. (2021). Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. International Journal of Molecular Sciences, 22(12), 6325. https://doi.org/10.3390/ijms22126325

Chicago Style (17th ed.) Citation

Antonioli, Luca, et al. "Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation." International Journal of Molecular Sciences 22, no. 12 (2021): 6325. https://doi.org/10.3390/ijms22126325.

MLA (9th ed.) Citation

Antonioli, Luca, et al. "Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation." International Journal of Molecular Sciences, vol. 22, no. 12, 2021, p. 6325, https://doi.org/10.3390/ijms22126325.